I’ll have 10 of those….

A still from the Humira "Volunteering” for arthritis ad campaign

What are the 10 most advertised prescription drugs in the US?

We often hear calls in Australia for a loosening of restrictions on drug advertising regulations, or of the harms doing this would entail.

As we know US media is awash in prescription drug advertising. Here are the 10 most advertised drugs on TV in the US in April 2017 (as reported by US industry website Fierce Pharma):

1. Humira
What is it? AbbVie anti-inflammatory drug
Total estimated spending: US$27 million (A$36.3 million) – down from US$31.5 million in March

2. Trulicity
What is it? Eli Lilly GLP-1 diabetes drug
Total estimated spending: US$20.8 million (A$28 million) – up from US$17 million in Feb

3. Lyrica
What is it? Pfizer seizure and pain drug
Total estimated spending: US$18.2 million (A$24.5 million)

4. Keytruda
What is it? Merck’s PD-L1 cancer fighter
Total estimated spending: US$14 million (A$18.8 million)

5. Breo
What is it? GlaxoSmithKline respiratory drug
Total estimated spending: $12.4 million

6. Xarelto
What is it? Johnson & Johnson clot-fighter
Total estimated spending: $12.32 million

7. Latuda
What is it? Sunovion Pharmaceutical antipsychotic
Total estimated spending: $12.26 million

8. Xeljanz XR
What is it? Pfizer oral rheumatoid arthritis therapy
Total estimated spending: $12 million

9. Movantik
What is it? AstraZeneca and Daiichi Sankyo treatment for opioid-induced constipation
Total estimated spending: $10.9 million

10. Taltz
What is it? Eli Lilly next-gen psoriasis treatment
Total estimated spending: $10.3 million

Previous The week in review
Next Should EC be a taboo subject?

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.


  1. Greg Kyle

    Maybe it’s just me, but under “What is it?”, I was expecting to see the generic name, rather than an indication. I would have hoped a journal for pharmacists would not be so shallow as to leave out any mention of the generic name. This is only helping pharma’s marketing effort to ‘cleanse’ their brands by ‘scrubbing’ any mention of generic names.

Leave a reply